Stock analysts at Wells Fargo & Co began coverage on shares of Change Healthcare (NASDAQ:CHNG) in a research note issued on Monday, MarketBeat Ratings reports. The firm set a “market perform” rating on the stock.
A number of other analysts also recently issued reports on the company. Cowen assumed coverage on Morphic in a research report on Monday. They issued an “outperform” rating for the company. Goldman Sachs Group downgraded Cadence Bancorp from a “buy” rating to a “neutral” rating and set a $18.00 target price for the company. in a research report on Monday. Piper Jaffray Companies downgraded M&T Bank from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $196.00 to $168.00 in a report on Monday. Cantor Fitzgerald began coverage on Fate Therapeutics in a research note on Monday. They issued an “overweight” rating and a $32.00 target price on the stock. Finally, Citigroup lowered Intercontinental Exchange from a “buy” rating to a “neutral” rating and lifted their target price for the company from $92.00 to $99.00 in a research note on Monday. One analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Change Healthcare has a consensus rating of “Buy” and a consensus target price of $19.04.
Shares of CHNG opened at $14.61 on Monday. Change Healthcare has a 1 year low of $13.26 and a 1 year high of $15.30.
About Change Healthcare
Change Healthcare Inc, an independent healthcare technology platform, provides data and analytics-driven solutions to improve clinical, financial, and patient engagement outcomes in the United States healthcare system. It operates in three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services.
Featured Story: What does a bar chart display?
Receive News & Ratings for Change Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Change Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.